Glucosamine and Farxiga drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glucosamine (glucosamine) and Farxiga (dapagliflozin). Common drug interactions include skin infection among females and gastrooesophageal reflux disease among males.

The phase IV clinical study analyzes what interactions people have when they take Glucosamine and Farxiga. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Glucosamine?

Glucosamine has active ingredients of glucosamine. It is often used in joint pain. eHealthMe is studying from 15,547 Glucosamine users. Check the latest studies of Glucosamine.

What is Farxiga?

Farxiga has active ingredients of dapagliflozin. It is often used in diabetes. eHealthMe is studying from 18,798 Farxiga users. Check the latest studies of Farxiga.

On Jul, 27, 2026

26 people who take Glucosamine and Farxiga together, and have interactions are studied.

Glucosamine and Farxiga drug interactions.

What are the common drug interactions of Glucosamine and Farxiga, by gender? *:

female:

Skin infection
Spinal stenosis (narrowing of spinal column)
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
Tenderness (pain or discomfort when an affected area is touched)
Weight decreased
Wound infection
Abdominal discomfort
Abdominal distension
Abdominal pain lower
Abdominal pain upper

male:

Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Abdominal pain
Renal failure (kidney dysfunction)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Urinary tract infection
Vision blurred
Aggression
Agitation (state of anxiety or nervous excitement)
Confusional state
Drug effect decreased

What are the common drug interactions of Glucosamine and Farxiga, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain
Bradycardia (abnormally slow heart action)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Dyspepsia (indigestion)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyperlipidaemia (presence of excess lipids in the blood)
Leukocytosis (increased white blood cells)
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

30-39:

n/a

40-49:

n/a

50-59:

Headache (pain in head)
Muscle spasms (muscle contraction)
Nausea (feeling of having an urge to vomit)
Breast enlargement
Chest pain
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Gait disturbance
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Glycosylated haemoglobin increased
Ingrowing nail

60+:

Diarrhoea
Abdominal pain upper
Nausea (feeling of having an urge to vomit)
Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
Rash
Red cell distribution width increased
Urticaria (rash of round, red welts on the skin that itch intensely)
Vomiting
Blood cholesterol increased
Blood thyroid stimulating hormone increased

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 23.08%
Type 2 Diabetes: 4 people, 15.38%
High Blood Pressure: 3 people, 11.54%
High Blood Cholesterol: 3 people, 11.54%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 7.69%
Prostate Cancer: 2 people, 7.69%
Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 2 people, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.69%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 2 people, 7.69%
Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Glucosamine and Farxiga?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously